NCT00748657 · OUTCOME
Number of Participants With Episodes and Grade of Adverse Events as Assessed by Common Terminology for Adverse Events Version 3.0
Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary · Source last updated 2019-07-23
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Up to 5 years
What was measured
Adverse Events at least possibly related to study agent.
Analysis population: Eligible and evaluable patients
Groups in this outcome
Grade 0
Number of patients who did not experience the specified AE (adverse event).
Grade 1 (CTCAE v 3.0)
Number of patients who experienced a grade 1 event using Common Terminology Criteria version 3.0
Grade 2 (CTCAE v 3.0)
Number of patients who experienced a grade 2 event using Common Terminology Criteria version 3.0
Grade 3 (CTCAE v 3.0)
Number of patients who experienced a grade 3 event using Common Terminology Criteria version 3.0
Grade 4 (CTCAE v 3.0)
Number of patients who experienced a grade 4 event using Common Terminology Criteria version 3.0
Grade 5 (CTCAE v 3.0)
Number of patients who experienced a grade 5 event using Common Terminology Criteria version 3.0
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
| Group | Source count |
|---|
| Grade 0 | 36 |
|---|
| Grade 1 (CTCAE v 3.0) | 36 |
|---|
| Grade 2 (CTCAE v 3.0) | 36 |
|---|
| Grade 3 (CTCAE v 3.0) | 36 |
|---|
| Grade 4 (CTCAE v 3.0) | 36 |
|---|
| Grade 5 (CTCAE v 3.0) | 36 |
|---|
Reported measurements
Leukopenia
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 32 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Thrombocytopenia
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 28 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 8 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Anemia
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 21 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 7 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 7 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Other Hematologic
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 33 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Allergy/Immunology
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 23 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 11 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Auditory/Ear
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 29 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 6 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Cardiac
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 15 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 6 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 9 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Coagulation
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 35 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Constitutional
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 12 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 10 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 13 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Dermatologic
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 17 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 14 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Endocrine
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 33 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Gastrointestinal
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 6 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 10 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 15 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Genitourinary/Renal
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 29 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Hemorrhage
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 17 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 18 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Infection
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 23 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 11 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Lymphatics
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 31 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Metabolic
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 13 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 10 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 8 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Musculoskeletal
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 30 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Neurosensory
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 21 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 13 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Other Neurological
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 22 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 12 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Ocular/Visual
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 30 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 6 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Pain
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 11 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 16 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 8 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Pulmonary
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 12 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 20 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Sexual/Reproductive
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 32 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Syndromes
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 35 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Vascular
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 35 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
Death, Not CTC coded
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Grade 0 | 35 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 1 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 2 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 3 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 4 (CTCAE v 3.0) | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Grade 5 (CTCAE v 3.0) | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 32
- group Id
- OG001
- value
- 2
- group Id
- OG002
- value
- 1
- group Id
- OG003
- value
- 1
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Leukopenia
- categories
- measurements
- group Id
- OG000
- value
- 28
- group Id
- OG001
- value
- 8
- group Id
- OG002
- value
- 0
- group Id
- OG003
- value
- 0
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Thrombocytopenia
- categories
- measurements
- group Id
- OG000
- value
- 21
- group Id
- OG001
- value
- 7
- group Id
- OG002
- value
- 7
- group Id
- OG003
- value
- 1
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Anemia
- categories
- measurements
- group Id
- OG000
- value
- 33
- group Id
- OG001
- value
- 2
- group Id
- OG002
- value
- 1
- group Id
- OG003
- value
- 0
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Other Hematologic
- categories
- measurements
- group Id
- OG000
- value
- 23
- group Id
- OG001
- value
- 11
- group Id
- OG002
- value
- 2
- group Id
- OG003
- value
- 0
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Allergy/Immunology
- categories
- measurements
- group Id
- OG000
- value
- 29
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 6
- group Id
- OG003
- value
- 1
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Auditory/Ear
- categories
- measurements
- group Id
- OG000
- value
- 15
- group Id
- OG001
- value
- 6
- group Id
- OG002
- value
- 9
- group Id
- OG003
- value
- 5
- group Id
- OG004
- value
- 1
- group Id
- OG005
- value
- 0
- title
- Cardiac
- categories
- measurements
- group Id
- OG000
- value
- 35
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 0
- group Id
- OG003
- value
- 1
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Coagulation
- categories
- measurements
- group Id
- OG000
- value
- 12
- group Id
- OG001
- value
- 10
- group Id
- OG002
- value
- 13
- group Id
- OG003
- value
- 1
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Constitutional
- categories
- measurements
- group Id
- OG000
- value
- 17
- group Id
- OG001
- value
- 14
- group Id
- OG002
- value
- 4
- group Id
- OG003
- value
- 1
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Dermatologic
- categories
- measurements
- group Id
- OG000
- value
- 33
- group Id
- OG001
- value
- 2
- group Id
- OG002
- value
- 1
- group Id
- OG003
- value
- 0
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Endocrine
- categories
- measurements
- group Id
- OG000
- value
- 6
- group Id
- OG001
- value
- 10
- group Id
- OG002
- value
- 15
- group Id
- OG003
- value
- 5
- group Id
- OG004
- value
- 0
- group Id
- OG005
- value
- 0
- title
- Gastrointestinal
- denoms
- counts
- group Id
- OG000
- value
- 36
- group Id
- OG001
- value
- 36
- group Id
- OG002
- value
- 36
- group Id
- OG003
- value
- 36
- group Id
- OG004
- value
- 36
- group Id
- OG005
- value
- 36
- units
- Participants
- description
- Adverse Events at least possibly related to study agent.
- groups
- description
- Number of patients who did not experience the specified AE (adverse event).
- id
- OG000
- title
- Grade 0
- description
- Number of patients who experienced a grade 1 event using Common Terminology Criteria version 3.0
- id
- OG001
- title
- Grade 1 (CTCAE v 3.0)
- description
- Number of patients who experienced a grade 2 event using Common Terminology Criteria version 3.0
- id
- OG002
- title
- Grade 2 (CTCAE v 3.0)
- description
- Number of patients who experienced a grade 3 event using Common Terminology Criteria version 3.0
- id
- OG003
- title
- Grade 3 (CTCAE v 3.0)
- description
- Number of patients who experienced a grade 4 event using Common Terminology Criteria version 3.0
- id
- OG004
- title
- Grade 4 (CTCAE v 3.0)
- description
- Number of patients who experienced a grade 5 event using Common Terminology Criteria version 3.0
- id
- OG005
- title
- Grade 5 (CTCAE v 3.0)
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Eligible and evaluable patients
- reporting Status
- POSTED
- time Frame
- Up to 5 years
- title
- Number of Participants With Episodes and Grade of Adverse Events as Assessed by Common Terminology for Adverse Events Version 3.0
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle